Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Impact of Inherited Bleeding Disorders on Peripartum Blood Loss: Insights from a Majority Hispanic Cohort Study

Kamilia N. Moalem, Thomas J. Harrington, Maya Bloomberg, Gerald A. Soff, Diana Marie Byrnes

Blood (2024) 144 (Supplement 1): 7690.

https://doi.org/10.1182/blood-2024-202488

Published: 2024

Journal Articles

The Association of Routine Hematologic Parameters and Overall Survival in Metastatic Solid Tumors and Aggressive Lymphoma

Dan Morgenstern Kaplan, Thomas Plate, IV, Asaad Trabolsi, Gil Hevroni, Diana Marie Byrnes, Gerald A. Soff

Blood (2024) 144 (Supplement 1): 7812.

https://doi.org/10.1182/blood-2024-204225

Published: 2024

Journal Articles

Predictors and Timing of Venous Thromboembolism in Lung Cancer

Thomas Plate, IV, Asaad Trabolsi, Rachel S. Kronenfeld, Leticia E. Campoverde, Dan Morgenstern Kaplan, Alyssa Mercadel, Michael Caballero, Wei Zhao, Gerald A. Soff

Blood (2023) 142 (Supplement 1): 2649.

https://doi.org/10.1182/blood-2023-180946

Published: 2023

Journal Articles

Predictors and Timing of Venous Thromboembolism in Lymphoma

Asaad Trabolsi, Thomas Plate, IV, Rachel S. Kronenfeld, Leticia E. Campoverde, Dan Morgenstern Kaplan, Alyssa Mercadel, Michael Caballero, Wei Zhao, Izidore S. Lossos, Craig H. Moskowitz, Gerald A. Soff

Blood (2023) 142 (Supplement 1): 2642.

https://doi.org/10.1182/blood-2023-173903

Published: 2023

Journal Articles

Thrombosis Rates and Use of Thromboprophylaxis after Discharge from Gynecologic Cancer-Related Surgery

Leticia E. Campoverde, Alyssa Mercadel, Dan Morgenstern Kaplan, Asaad Trabolsi, Thomas Plate, IV, Rachel S. Kronenfeld, Michael Caballero, Wei Zhao, Matthew P. Schlumbrecht, Gerald A. Soff

Blood (2023) 142 (Supplement 1): 5530.

https://doi.org/10.1182/blood-2023-180225

Published: 2023

Journal Articles

Two Randomized Controlled Trials of Romiplostim for Chemotherapy-Induced Thrombocytopenia in Patients with Solid Tumors

Hanny Al-Samkari, Caglayan Geredeli, Cagatay Arslan, Ippokratis Korantzis, Gamze Gokoz Dogu, Marina Nechaeva, Mercedes Salgado Fernandez, Beatriz Gonzalez Astorga, Valeriy Yordanov, Tudor-eliade Ciuleanu, Charles Bowers, Armando Armas, Florian Scotte, Johnny Camargo, César Muñoz, Paul Bunn, David J. Kuter, Gerald A. Soff

Blood (2022) 140 (Supplement 1): 11250–11252.

https://doi.org/10.1182/blood-2022-155931

Published: 2022

Journal Articles

Rivaroxaban after laparoscopic cancer surgery

Gerald A. Soff

Blood (2022) 140 (8): 804–805.

https://doi.org/10.1182/blood.2022016866

Published: 2022

Journal Articles

Efficacy and Safety of Extended Use of Romiplostim Treatment for Chemotherapy-Induced Thrombocytopenia

Cy R Wilkins, Jocelyn Ortiz, Leah Gilbert, Shen Yin, Jodi V. Mones, Rekha Parameswaran, Simon Mantha, Gerald A. Soff

Blood (2021) 138 (Supplement 1): 2075.

https://doi.org/10.1182/blood-2021-145958

Published: 2021

Journal Articles

Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors

Blood (2021) 137 (15): 2103–2113.

https://doi.org/10.1182/blood.2020007488

Published: 2021

Includes: Supplemental data

Journal Articles

Development and Baseline Characterization of a Thrombosis Risk Alert Tool: A Quality Assessment Project

Claire M Sathe, MD, Chester Poon, Debra M. M Sarasohn, MD, Leah Gilbert, Alok A Khorana, MD, Simon Mantha, MDMPH, Gerald A. Soff, MD

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-142037

Published: 2020

Journal Articles

Prediction of COVID-19 Mortality in Patients with Cancer

Simon Mantha, MDMPH, Justin Jee, Gerald A. Soff, MD, Melissa S. Pessin, MD PhD

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-138576

Published: 2020

Journal Articles

Machine Learning for Prediction of Cancer-Associated Venous Thromboembolism

Simon Mantha, MDMPH, Andrew Dunbar, MD, Kelly L. Bolton, MD PhD, Sean Devlin, PhD, Dmitriy Gorenshteyn, PhD, Mark Donoghue, PhD, Maria E. Arcila, MD, Gerald A. Soff, MD

Blood (2020) 136 (Supplement 1): 37.

https://doi.org/10.1182/blood-2020-138579

Published: 2020

Journal Articles

Extended Mutational Profiling By MSK-IMPACT TM Identifies Mutations Predicting Thromboembolic Risk in Patients with Solid Tumor Malignancy

Andrew Dunbar, MD, Kelly Bolton, MD PhD, Sean M. Devlin, PhD, Francisco Sanchez-Vega, PhD, Jianjiong Gao, PhD, Jodi V. Mones, MD, Jonathan M. Wills, BA, Daniel Kelly, MS, Mirko Farina, MD, Sirish Kishore, MD, Krishna Juluru, MD, Neil Iyengar, MD, David M. Hyman, MD, Ahmet Zehir, PhD, Wungki Park, MD, Alok A Khorana, MD, Gerald A. Soff, MD, Simon Mantha, MDMPH

Blood (2019) 134 (Supplement_1): 633.

https://doi.org/10.1182/blood-2019-124242

Published: 2019

Journal Articles

Safe and Effective Use of Rivaroxaban for Treatment of Cancer Associated Venous Thromboembolic Disease

Gerald A. Soff, MD, Debra M. M Sarasohn, MD, Eva S Haegler-Laube, MD, Sean M Devlin, PhD, Yimei Miao, BS, Gemma Bendheim, BA, Jeanette Batista, RN, Jonathan Wills, Jodi V Mones, MD, Cy Wilkins, MD, Simon H Mantha, MD MPH

Blood (2018) 132 (Supplement 1): 2536.

https://doi.org/10.1182/blood-2018-99-115506

Published: 2018

Journal Articles

Rivaroxaban Thromboprophylaxis in High-Risk Ambulatory Cancer Patients Receiving Systemic Therapy: Results of a Randomized Clinical Trial (CASSINI)

Blood (2018) 132 (Supplement 1): LBA-1.

https://doi.org/10.1182/blood-2018-120738

Published: 2018

Journal Articles

Cancer-Associated Thrombosis: Anatomic Distribution of the Index Event Is Not a Reliable Predictor of Recurrence Risk

Gerald A. Soff, MD, Jeanette Batista, RN, Debra M. M Sarasohn, MD, Jodi V Mones, MD, Cy Wilkins, MD, Eva S Haegler-Laube, MD, Sean M Devlin, PhD, Yimei Miao, BS, Gemma Bendheim, BA, Jonathan Wills, Simon H Mantha, MD MPH

Blood (2018) 132 (Supplement 1): 1252.

https://doi.org/10.1182/blood-2018-99-115538

Published: 2018

Journal Articles

Folate Testing and Deficiency in Hospitalized Cancer Patients

Zachary D. Epstein-Peterson, MD, Gerald A. Soff, MD, Maly Fenelus, MD, Deborah Korenstein, MD

Blood (2018) 132 (Supplement 1): 5814.

https://doi.org/10.1182/blood-2018-99-117073

Published: 2018

Journal Articles

Efficacy and Thrombotic Adverse Events of Romiplostim Use in Patients with Thrombocytopenia Related to Underlying Malignancies

Valery J Li, MD, Yimei Miao, BS, Cy Wilkins, MD, Gerald A. Soff, MD

Blood (2017) 130 (Supplement 1): 2324.

https://doi.org/10.1182/blood.V130.Suppl_1.2324.2324

Published: 2017

Journal Articles

Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT). Results of a Phase 2 Trial

Gerald A. Soff, MD, Yimei Miao, BS, Sean M. Devlin, PhD, Simon Mantha, MD MPH, Jodi V Mones, MD, Valery J Li, MD, Ghassan K Abou-Alfa, MD MBA, Andrea Cercek, MD, Nancy Kemeny, MD, Rekha Parameswaran, MD

Blood (2017) 130 (Supplement 1): 289.

https://doi.org/10.1182/blood.V130.Suppl_1.289.289

Published: 2017

Journal Articles

Reduced Emergency Room Utilization for Initiation of Anticoagulation with Rivaroxaban Treatment of Cancer-Associated Thrombosis

Aaron P Soff, Judy Dong, MD, Simon Mantha, MD MPH, Gerald A. Soff, MD

Blood (2016) 128 (22): 2619.

https://doi.org/10.1182/blood.V128.22.2619.2619

Published: 2016

NARROW

Impact of Inherited Bleeding Disorders on Peripartum Blood Loss: Insights from a Majority Hispanic Cohort Study

The Association of Routine Hematologic Parameters and Overall Survival in Metastatic Solid Tumors and Aggressive Lymphoma

Predictors and Timing of Venous Thromboembolism in Lung Cancer

Predictors and Timing of Venous Thromboembolism in Lymphoma

Thrombosis Rates and Use of Thromboprophylaxis after Discharge from Gynecologic Cancer-Related Surgery

Two Randomized Controlled Trials of Romiplostim for Chemotherapy-Induced Thrombocytopenia in Patients with Solid Tumors

Rivaroxaban after laparoscopic cancer surgery

Efficacy and Safety of Extended Use of Romiplostim Treatment for Chemotherapy-Induced Thrombocytopenia

Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors

Development and Baseline Characterization of a Thrombosis Risk Alert Tool: A Quality Assessment Project

Prediction of COVID-19 Mortality in Patients with Cancer

Machine Learning for Prediction of Cancer-Associated Venous Thromboembolism

Extended Mutational Profiling By MSK-IMPACT TM Identifies Mutations Predicting Thromboembolic Risk in Patients with Solid Tumor Malignancy

Safe and Effective Use of Rivaroxaban for Treatment of Cancer Associated Venous Thromboembolic Disease

Rivaroxaban Thromboprophylaxis in High-Risk Ambulatory Cancer Patients Receiving Systemic Therapy: Results of a Randomized Clinical Trial (CASSINI)

Cancer-Associated Thrombosis: Anatomic Distribution of the Index Event Is Not a Reliable Predictor of Recurrence Risk

Folate Testing and Deficiency in Hospitalized Cancer Patients

Efficacy and Thrombotic Adverse Events of Romiplostim Use in Patients with Thrombocytopenia Related to Underlying Malignancies

Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT). Results of a Phase 2 Trial

Reduced Emergency Room Utilization for Initiation of Anticoagulation with Rivaroxaban Treatment of Cancer-Associated Thrombosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only